Variables used were lowest hemoglobin during admission, lowest platelet count, lowest ANC, sex, BMI, medical history, ACE inhibitor use before admission, smoking status, age, and cancer status (having no cancer vs. having solid cancer vs. having hematologic cancer). This evidence concerns the gene ACE and cancer.